Cargando…
ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells
The response to Poly (ADP-ribose) polymerase inhibitors (PARPi) is dictated by homologous recombination (HR) DNA repair and the abundance of lesions that trap PARP enzymes. It remains unclear, however, if the established role of PARP in promoting chromatin accessibility impacts viability in these se...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880902/ https://www.ncbi.nlm.nih.gov/pubmed/33462394 http://dx.doi.org/10.1038/s41556-020-00624-3 |
_version_ | 1783650766639071232 |
---|---|
author | Verma, Priyanka Zhou, Yeqiao Cao, Zhendong Deraska, Peter V. Deb, Moniher Arai, Eri Li, Weihua Shao, Yue Puentes, Laura Li, Yiwen Patankar, Sonali Mach, Robert H. Faryabi, Robert B. Shi, Junwei Greenberg, Roger A. |
author_facet | Verma, Priyanka Zhou, Yeqiao Cao, Zhendong Deraska, Peter V. Deb, Moniher Arai, Eri Li, Weihua Shao, Yue Puentes, Laura Li, Yiwen Patankar, Sonali Mach, Robert H. Faryabi, Robert B. Shi, Junwei Greenberg, Roger A. |
author_sort | Verma, Priyanka |
collection | PubMed |
description | The response to Poly (ADP-ribose) polymerase inhibitors (PARPi) is dictated by homologous recombination (HR) DNA repair and the abundance of lesions that trap PARP enzymes. It remains unclear, however, if the established role of PARP in promoting chromatin accessibility impacts viability in these settings. Using a CRISPR-based screen, we identify the PAR-binding chromatin remodeler, ALC1/CHD1L, as a key determinant of PARPi toxicity in HR-deficient cells. ALC1 loss reduced viability of BRCA-mutant cells and enhanced sensitivity to PARPi by up to 250-fold, while overcoming several resistance mechanisms. ALC1 deficiency reduced chromatin accessibility concomitant with a decrease in the association of base damage repair factors. This resulted in an accumulation of replication associated DNA damage, increased PARP trapping, and a reliance on HR. These findings establish PAR-dependent chromatin remodeling as a mechanistically distinct aspect of PARPi responses and therapeutic target in HR-deficient cancers. |
format | Online Article Text |
id | pubmed-7880902 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
record_format | MEDLINE/PubMed |
spelling | pubmed-78809022021-07-18 ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells Verma, Priyanka Zhou, Yeqiao Cao, Zhendong Deraska, Peter V. Deb, Moniher Arai, Eri Li, Weihua Shao, Yue Puentes, Laura Li, Yiwen Patankar, Sonali Mach, Robert H. Faryabi, Robert B. Shi, Junwei Greenberg, Roger A. Nat Cell Biol Article The response to Poly (ADP-ribose) polymerase inhibitors (PARPi) is dictated by homologous recombination (HR) DNA repair and the abundance of lesions that trap PARP enzymes. It remains unclear, however, if the established role of PARP in promoting chromatin accessibility impacts viability in these settings. Using a CRISPR-based screen, we identify the PAR-binding chromatin remodeler, ALC1/CHD1L, as a key determinant of PARPi toxicity in HR-deficient cells. ALC1 loss reduced viability of BRCA-mutant cells and enhanced sensitivity to PARPi by up to 250-fold, while overcoming several resistance mechanisms. ALC1 deficiency reduced chromatin accessibility concomitant with a decrease in the association of base damage repair factors. This resulted in an accumulation of replication associated DNA damage, increased PARP trapping, and a reliance on HR. These findings establish PAR-dependent chromatin remodeling as a mechanistically distinct aspect of PARPi responses and therapeutic target in HR-deficient cancers. 2021-01-18 2021-02 /pmc/articles/PMC7880902/ /pubmed/33462394 http://dx.doi.org/10.1038/s41556-020-00624-3 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Verma, Priyanka Zhou, Yeqiao Cao, Zhendong Deraska, Peter V. Deb, Moniher Arai, Eri Li, Weihua Shao, Yue Puentes, Laura Li, Yiwen Patankar, Sonali Mach, Robert H. Faryabi, Robert B. Shi, Junwei Greenberg, Roger A. ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells |
title | ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells |
title_full | ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells |
title_fullStr | ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells |
title_full_unstemmed | ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells |
title_short | ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells |
title_sort | alc1 links chromatin accessibility to parp inhibitor response in homologous recombination-deficient cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880902/ https://www.ncbi.nlm.nih.gov/pubmed/33462394 http://dx.doi.org/10.1038/s41556-020-00624-3 |
work_keys_str_mv | AT vermapriyanka alc1linkschromatinaccessibilitytoparpinhibitorresponseinhomologousrecombinationdeficientcells AT zhouyeqiao alc1linkschromatinaccessibilitytoparpinhibitorresponseinhomologousrecombinationdeficientcells AT caozhendong alc1linkschromatinaccessibilitytoparpinhibitorresponseinhomologousrecombinationdeficientcells AT deraskapeterv alc1linkschromatinaccessibilitytoparpinhibitorresponseinhomologousrecombinationdeficientcells AT debmoniher alc1linkschromatinaccessibilitytoparpinhibitorresponseinhomologousrecombinationdeficientcells AT araieri alc1linkschromatinaccessibilitytoparpinhibitorresponseinhomologousrecombinationdeficientcells AT liweihua alc1linkschromatinaccessibilitytoparpinhibitorresponseinhomologousrecombinationdeficientcells AT shaoyue alc1linkschromatinaccessibilitytoparpinhibitorresponseinhomologousrecombinationdeficientcells AT puenteslaura alc1linkschromatinaccessibilitytoparpinhibitorresponseinhomologousrecombinationdeficientcells AT liyiwen alc1linkschromatinaccessibilitytoparpinhibitorresponseinhomologousrecombinationdeficientcells AT patankarsonali alc1linkschromatinaccessibilitytoparpinhibitorresponseinhomologousrecombinationdeficientcells AT machroberth alc1linkschromatinaccessibilitytoparpinhibitorresponseinhomologousrecombinationdeficientcells AT faryabirobertb alc1linkschromatinaccessibilitytoparpinhibitorresponseinhomologousrecombinationdeficientcells AT shijunwei alc1linkschromatinaccessibilitytoparpinhibitorresponseinhomologousrecombinationdeficientcells AT greenbergrogera alc1linkschromatinaccessibilitytoparpinhibitorresponseinhomologousrecombinationdeficientcells |